Last $3.42 USD
Change Today 0.00 / 0.00%
Volume 0.0
CEMI On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

chembio diagnostics inc (CEMI) Snapshot

Open
$3.42
Previous Close
$3.45
Day High
$3.42
Day Low
$3.40
52 Week High
08/1/13 - $5.01
52 Week Low
05/8/14 - $2.83
Market Cap
32.7M
Average Volume 10 Days
18.3K
EPS TTM
$-0.01
Shares Outstanding
9.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHEMBIO DIAGNOSTICS INC (CEMI)

Related News

No related news articles were found.

chembio diagnostics inc (CEMI) Related Businessweek News

No Related Businessweek News Found

chembio diagnostics inc (CEMI) Details

Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The company’s products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a Syphilis multiplex test for the detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies and antigens. Chembio Diagnostics, Inc. sells its products under STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology products. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.

206 Employees
Last Reported Date: 03/6/14
Founded in 1985

chembio diagnostics inc (CEMI) Top Compensated Officers

Chief Operating Officer
Total Annual Compensation: $239.6K
Senior Vice President of Research & Developme...
Total Annual Compensation: $337.1K
Vice President of Regulatory Affairs, Quality...
Total Annual Compensation: $229.8K
Compensation as of Fiscal Year 2013.

chembio diagnostics inc (CEMI) Key Developments

Chembio Diagnostics, Inc. Provides Sales Guidance for the Year 2013

Chembio Diagnostics, Inc. provided sales guidance for the year 2013. The company expects the level of sales in 2014 to be similar to that in 2013.

Chembio Diagnostics, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

Chembio Diagnostics, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported total revenues of $5.81 million were down 13% compared with total revenues of $6.68 million in the prior-year period. Operating loss was $383,000, compared with operating income of $487,000 for the prior-year period. Net loss was $225,000, or $0.02 per basic and diluted share, compared with net income of $317,000, or $0.04 per basic and diluted share, for the prior-year period. Net cash used in operating activities was $650,304 compared to net cash provided by operating activities of $57,438 a year ago.

Chembio Diagnostics, Inc. to Report Q1, 2014 Results on May 08, 2014

Chembio Diagnostics, Inc. announced that they will report Q1, 2014 results at 9:00 AM, Eastern Standard Time on May 08, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CEMI:US $3.42 USD 0.00

CEMI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $39.22 USD 0.00
OraSure Technologies Inc $8.30 USD 0.00
Trinity Biotech PLC $23.10 USD 0.00
View Industry Companies
 

Industry Analysis

CEMI

Industry Average

Valuation CEMI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 1.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMBIO DIAGNOSTICS INC, please visit www.chembio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.